logo

5.32

5.32 (-0.20%)

As of Feb 24, 2021

Viracta Therapeutics, Inc. [SNSS]

Source: 

Company Overview

Viracta is a clinical-stage, precision oncology company focused on advancing new medicines for the treatment of virus-associated malignancies. The association of viruses and cancer has been well characterized, and Viracta’s lead program is focused on cancers associated with the Epstein-Barr virus (“EBV”).

CountryUnited States
Headquarterscardiffcalifornia
Phone Number858-400-8470
Industry
manufacturing
CEOMark Rothera
Websitehttps://www.viracta.com